EUVIMEDEUVIMED entdecken
Crossref

Therapeutic Potential of Phytocompounds Gentisic Acid and Alpha Resorcylic Acid against Alzheimer’s Disease: A Network Pharmacology, In Silico, and In Vitro Approach

Urvashi Soni, Rohini Pujari

Cell Biochemistry and Biophysics · 10.11.2025 · 84 (1) · 1289-1308

DOI: 10.1007/s12013-025-01944-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Biochemistry and Biophysics, online erschienen am 10.11.2025. Verfasst von Urvashi Soni und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Health Sciences and Technology, Dr. Vishwanath Karad MIT World Peace University, Pune, 411038, Maharashtra, India. Hauptthemen laut MEDLINE: Alzheimer Disease, Gentisates, Cholinesterase Inhibitors, Hydroxybenzoates. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 52 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder marked by memory loss, cognitive decline, and impaired cholinergic signaling. Natural polyphenolic compounds have gained attention for their antioxidant, anti-inflammatory, and multi-target neuroprotective effects. In this study, we explored the potential of gentisic acid and alpha-resorcylic acid as therapeutic candidates against AD using a combination of computational and experimental approaches. We first identified potential protein targets for these compounds using SwissTargetPrediction and STITCH databases and compiled 67 AD-related genes from GeneCards. Network analysis highlighted acetylcholinesterase (AChE) as a key target, supported by its established role in AD pathology. Molecular docking showed that gentisic acid and alpha-resorcylic acid bind effectively to AChE, with docking scores of − 6.6 and − 6.9 kcal/mol, respectively, compared to standard drugs donepezil (− 9.2 kcal/mol) and galantamine (− 7.7 kcal/mol). Molecular dynamics simulations over 100 ns confirmed the stability of these ligand–protein complexes, with RMSD values remaining below 3 Å and consistent hydrogen-bond interactions throughout the simulation. Experimental validation revealed that both compounds inhibit AChE in a concentration-dependent manner, with IC₅₀ values of 3.59 µg/mL for gentisic acid and 89.99 µg/mL for alpha-resorcylic acid. Functional enrichment analyses further indicated that these compounds may influence multiple pathways relevant to AD, including Tau phosphorylation, neuropeptide receptor activity, glycerolipid metabolism, and anti-inflammatory signaling. Together, these findings suggest that gentisic acid and alpha-resorcylic acid can act as multi-target agents with promising neuroprotective effects. Their moderate binding to AChE, coupled with favorable pharmacological properties, positions them as potential leads for the development of novel therapies for AD. These results provide a strong foundation for future preclinical and clinical investigations into their therapeutic applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseGentisatesCholinesterase InhibitorsHydroxybenzoatesMolecular Docking SimulationHumansMolecular Dynamics SimulationAcetylcholinesteraseNetwork PharmacologyNeuroprotective AgentsProtein Binding

Stichwörter der Autor:innen

Alpha resorcylic acidAlzheimer’s diseaseGentisic acidMolecular dockingMolecular dynamics simulationNetwork pharmacology

Substanzen

Gentisates2,5-dihydroxybenzoic acidAcetylcholinesteraseCholinesterase InhibitorsHydroxybenzoatesNeuroprotective Agents

Autor:innen und Institutionen

  • School of Health Sciences and Technology, Dr. Vishwanath Karad MIT World Peace University, Pune, 411038, Maharashtra, India.
  • School of Health Sciences and Technology, Dr. Vishwanath Karad MIT World Peace University, Pune, 411038, Maharashtra, India. rohinirpujari@gmail.com.

Zitieren

APA

Soni, U., & Pujari, R. (2025). Therapeutic Potential of Phytocompounds Gentisic Acid and Alpha Resorcylic Acid against Alzheimer’s Disease: A Network Pharmacology, In Silico, and In Vitro Approach. Cell Biochemistry and Biophysics, 84(1), 1289-1308. https://doi.org/10.1007/s12013-025-01944-7

Vancouver

Soni U, Pujari R. Therapeutic Potential of Phytocompounds Gentisic Acid and Alpha Resorcylic Acid against Alzheimer’s Disease: A Network Pharmacology, In Silico, and In Vitro Approach. Cell Biochemistry and Biophysics. 2025;84(1):1289-1308. doi:10.1007/s12013-025-01944-7

BibTeX
@article{Soni2025,
  author = {Soni, Urvashi and Pujari, Rohini},
  title = {Therapeutic Potential of Phytocompounds Gentisic Acid and Alpha Resorcylic Acid against Alzheimer’s Disease: A Network Pharmacology, In Silico, and In Vitro Approach},
  journal = {Cell Biochemistry and Biophysics},
  year = {2025},
  volume = {84},
  number = {1},
  pages = {1289--1308},
  doi = {10.1007/s12013-025-01944-7}
}
Kostenlos starten →